✦ LIBER ✦

Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma

✍ Scribed by Fernando Rivera; Maica Galán; Josep Tabernero; Andres Cervantes; Mª Eugenia Vega-Villegas; Javier Gallego; Berta Laquente; Edith Rodríguez; Alfredo Carrato; Pilar Escudero; Bartomeu Massutí; Vicente Alonso-Orduña; Adelaida Cardenal; Alberto Sáenz; Jordi Giralt; Ana Lucia Yuste; Antonio Antón; Enrique Aranda; On Behalf of the Spanish Cooperative Group for Digestive Tumour Therapy (TTD)

Publisher: Springer
Year: 2010
Tongue: English
Weight: 351 KB
Volume: 67
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1285-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of weekly fractionated

A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer

✍ Hei-Cheul Jeung; Sun Young Rha; Sung Hoon Noh; Jae Kyung Roh; Hyun Cheol Chung 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 308 KB

Phase II study of sequential cisplatin p

Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma

✍ Fotios Loupakis; Gianluca Masi; Lorenzo Fornaro; Enrico Vasile; Giacomo Allegrin 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 233 KB

Randomized phase II study of gemcitabine

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

✍ Jerome Landry; Paul J. Catalano; Charles Staley; Wayne Harris; John Hoffman; Mar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Sequential chemotherapy with dose-dense

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial

✍ Matteo Dalla Chiesa; Gianluca Tomasello; Sebastiano Buti; Rodrigo Kraft Rovere; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 277 KB